)
Edge3 Apr 2026
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries (TEVA) investor relations material
Teva Pharmaceutical Industries Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary31 Mar, 2026
Executive summary
Annual meeting scheduled for May 28, 2026, in a virtual-only format at 4:00 p.m. Israel time / 9:00 a.m. Eastern time.
Proxy materials, including the proxy statement and annual report, are available online, with options for shareholders to request paper or email copies by May 7, 2026.
Shareholders must be on record as of April 6, 2026, to vote at the meeting.
Voting matters and shareholder proposals
Proposal 1: Appointment of Dr. Sol J. Barer as director until the 2029 annual meeting.
Proposal 2: Advisory vote to approve compensation for named executive officers.
Proposal 3: Appointment of Kesselman & Kesselman (PwC) as independent auditor until the 2027 annual meeting.
Board recommends voting FOR all proposals.
Shareholders will also consider annual consolidated financial statements for the year ended December 31, 2025.
Board of directors and corporate governance
Board recommends the reappointment of Dr. Sol J. Barer as director for a term ending at the 2029 annual meeting.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Teva Pharmaceutical Industries
- 2025 saw robust growth, innovation, and governance, with key votes on leadership and compensation ahead.TEVA
Proxy filing31 Mar 2026 - Biopharma transition accelerates with strong growth, major launches, and robust pipeline ahead.TEVABarclays 28th Annual Global Healthcare Conference10 Mar 2026
- Accelerating biopharma transformation with innovative launches and strong pipeline momentum.TEVALeerink Global Healthcare Conference 20269 Mar 2026
- Duvakitug maintained robust, durable efficacy and safety for 44 weeks in UC and CD studies.TEVAStudy result17 Feb 2026
- Immunology pipeline advances with AI-designed antibodies and pivotal IL-15 and TL1A programs.TEVAPiper Sandler Virtual Novel Targets in Immunology Symposium13 Feb 2026
- Seven quarters of growth and innovative launches drive margin expansion and future targets.TEVA43rd Annual J.P. Morgan Healthcare Conference 20253 Feb 2026
- 2025 delivered 4% revenue growth, margin expansion, and strong innovative brand performance.TEVAQ4 20253 Feb 2026
- Atebimetinib plus chemo achieved 86% nine-month survival in first-line pancreatic cancer, nearly double standard care.TEVAStudy Update3 Feb 2026
- Q2 revenue up 7–11% to $4.2B, guidance raised, generics and AUSTEDO drive growth.TEVAQ2 20242 Feb 2026
Next Teva Pharmaceutical Industries earnings date
Q1 202629 Apr, 2026
Teva Pharmaceutical Industries
Next Teva Pharmaceutical Industries earnings date
Q1 202629 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage